Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000258847> ?p ?o ?g. }
- W2000258847 endingPage "394" @default.
- W2000258847 startingPage "383" @default.
- W2000258847 abstract "Nitric oxide (NO) is produced in physiological and pathophysiological conditions by three distinct isoforms of NO synthase (NOS): endothelial NOS (ecNOS), inducible NOS (iNOS), and brain NOS (bNOS). Selective inhibition of iNOS may be beneficial in various forms of shock and inflammation, whereas inhibition of bNOS may protect against neuroinjury. This article surveys the enzymatic mechanism of NO production, lists the strategies and pharmacological tools for selective inhibition of distinct NOS isoforms, and considers the side-effects of the various approaches. Selective inhibition of NOS isoforms is achieved by: (a) targeting the differential co-factor (calmodulin or tetrahydrobiopterin) requirement of various NOS isoforms, and NOS; (b) targeting the differential substrate requirements of cells expressing various isoforms of NOS (L-arginine uptake blockers or arginase); (c) the use of pharmacological agents that are selectively taken up by cells expressing various isoforms of NOS (7-nitroindazole); or (d) developing pharmacological NOS inhibitors with isoform specificity. The amino acid-based NOS inhibitor, NG-nitro-L-arginine, shows a preference for ecNOS and bNOS over iNOS, whereas L-N6-(1-iminoethyl)lysine is selective for iNOS over bNOS. Certain non-amino acid-based small molecules, such as aminoguanidine and certain S-alkylated isothioureas, also express selectivity towards iNOS and have anti-inflammatory and anti-shock properties. 7-nitroindazole, a bNOS-selective inhibitor, protects in central nervous system injury. Clearly, there are a number of distinct approaches that are worthy of further research efforts in order to achieve even more selective targeting of various NOS isoforms" @default.
- W2000258847 created "2016-06-24" @default.
- W2000258847 creator A5029790590 @default.
- W2000258847 creator A5058049602 @default.
- W2000258847 date "1996-02-01" @default.
- W2000258847 modified "2023-10-01" @default.
- W2000258847 title "Selective pharmacological inhibition of distinct nitric oxide synthase isoforms" @default.
- W2000258847 cites W1495441076 @default.
- W2000258847 cites W1513375223 @default.
- W2000258847 cites W1538844921 @default.
- W2000258847 cites W1558486290 @default.
- W2000258847 cites W1586512411 @default.
- W2000258847 cites W1587377302 @default.
- W2000258847 cites W1589961435 @default.
- W2000258847 cites W1599900714 @default.
- W2000258847 cites W1675755394 @default.
- W2000258847 cites W1834041853 @default.
- W2000258847 cites W1917982022 @default.
- W2000258847 cites W1946153048 @default.
- W2000258847 cites W1946442393 @default.
- W2000258847 cites W1957404430 @default.
- W2000258847 cites W1963807076 @default.
- W2000258847 cites W1967245379 @default.
- W2000258847 cites W1968145787 @default.
- W2000258847 cites W1970752465 @default.
- W2000258847 cites W1971825359 @default.
- W2000258847 cites W1972845367 @default.
- W2000258847 cites W1972929108 @default.
- W2000258847 cites W1975627247 @default.
- W2000258847 cites W1975936713 @default.
- W2000258847 cites W1979994394 @default.
- W2000258847 cites W1980407353 @default.
- W2000258847 cites W1980895604 @default.
- W2000258847 cites W1986878207 @default.
- W2000258847 cites W1992301407 @default.
- W2000258847 cites W1992636096 @default.
- W2000258847 cites W1996054128 @default.
- W2000258847 cites W1999873010 @default.
- W2000258847 cites W2001338847 @default.
- W2000258847 cites W2002069556 @default.
- W2000258847 cites W2005744476 @default.
- W2000258847 cites W2007484365 @default.
- W2000258847 cites W2007842608 @default.
- W2000258847 cites W2009006737 @default.
- W2000258847 cites W2010164098 @default.
- W2000258847 cites W2010707246 @default.
- W2000258847 cites W2010920613 @default.
- W2000258847 cites W2011730327 @default.
- W2000258847 cites W2013944939 @default.
- W2000258847 cites W2021117769 @default.
- W2000258847 cites W2024191096 @default.
- W2000258847 cites W2024401413 @default.
- W2000258847 cites W2026039680 @default.
- W2000258847 cites W2027071001 @default.
- W2000258847 cites W2031383268 @default.
- W2000258847 cites W2037066135 @default.
- W2000258847 cites W2037597903 @default.
- W2000258847 cites W2038098772 @default.
- W2000258847 cites W2040893865 @default.
- W2000258847 cites W2045846314 @default.
- W2000258847 cites W2047362612 @default.
- W2000258847 cites W2048398189 @default.
- W2000258847 cites W2049786479 @default.
- W2000258847 cites W2050954221 @default.
- W2000258847 cites W2054345018 @default.
- W2000258847 cites W2055462751 @default.
- W2000258847 cites W2057421768 @default.
- W2000258847 cites W2059432819 @default.
- W2000258847 cites W2065750772 @default.
- W2000258847 cites W2067560741 @default.
- W2000258847 cites W2068332364 @default.
- W2000258847 cites W2069174503 @default.
- W2000258847 cites W2070965761 @default.
- W2000258847 cites W2071438280 @default.
- W2000258847 cites W2072960344 @default.
- W2000258847 cites W2075068003 @default.
- W2000258847 cites W2075100842 @default.
- W2000258847 cites W2075538547 @default.
- W2000258847 cites W2077530348 @default.
- W2000258847 cites W2077824574 @default.
- W2000258847 cites W2077943481 @default.
- W2000258847 cites W2083285811 @default.
- W2000258847 cites W2083854039 @default.
- W2000258847 cites W2084045564 @default.
- W2000258847 cites W2085832634 @default.
- W2000258847 cites W2086641908 @default.
- W2000258847 cites W2086955825 @default.
- W2000258847 cites W2089537781 @default.
- W2000258847 cites W2090653600 @default.
- W2000258847 cites W2093636423 @default.
- W2000258847 cites W2094470225 @default.
- W2000258847 cites W2101392591 @default.
- W2000258847 cites W2105821269 @default.
- W2000258847 cites W2111775919 @default.
- W2000258847 cites W2114298357 @default.
- W2000258847 cites W2116660695 @default.
- W2000258847 cites W2117388675 @default.
- W2000258847 cites W2121764152 @default.